Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-07-19

FDA Approved: CLONAZEPAM — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Accord Healthcare's clonazepam (generic clonazepam), resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonazepam (Clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)